Battle looms over Plavix and Lipitor market

Korea’s major drug makers and two multinational companies – Pfizer and Sanofi-Aventis - are set for a fresh battle for leadership in the domestic prescription Plavix and Lipitor markets.

1) Plavix
The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix as chemically modified drugs developed by Chong Kun Dang and Daewoong have been eligible for nati...